In a recent study no connection was found between the
level of exposition to statins in the population and the incidence or mortality
from heart attack (Nilsson et al 2011). The use rate of statins increased
almost three times for both men and women between 1998 and 2002. However, the
change in statin use from 1998 to 2000 showed no correlation to the change in heart
attack mortality. They concluded, “despite a widespread and increasing
utilisation of statins, no correlation to the incidence or mortality of AMI (heart
attack) could be detected.” It should
be highlighted that all these researchers are medical doctors or working in a
medical establishment.
The drugs don’t work but have serious side
effects including recent studies showing increases in diabetes and breast
cancer. Although there are many
more serous side effects.
In one study Atorvastatin (a statin drug
used to lower cholesterol) increases the risk for new-onset type 2 diabetes,
according to an analysis of three large trials published in the Journal of the
American College of Cardiology. (The trials, as well as this analysis, were
sponsored by atorvastatin's manufacturer). Researchers were responding to a
2010 Lancet meta-analysis, which found an increased risk for new-onset diabetes
after all statin use and were trying to show their drug was not so bad. In the
meta analysis released in the Lancet, using data from 13 randomized trials
comprising some 90,000 subjects, found a 9% increase in diabetes risk among
those receiving statins compared with controls. The statin-diabetes association
was stronger with increasing age and given these drugs are give to older people
this is of even more concern. The authors calculate that 255 patients would
have to be treated with statins for 4 years to produce an additional case of
diabetes. This compares to the need to treat around 300 people with statin
drugs to reduce the risk of heart attack (not death) by one or according to the
research above no reduction at all. However, the medical profession continue to use relative
statistics and say they benefit by 30 or more percent. Obviously these doctors failed
stats at university or more likely did not do them.
A recent study (McDougall et al September 2013)
found current users of statins for 10 years or longer had a 1.83-to 1.97-fold
increased respectively for Ductal and Lobular Breast Cancer. In their
conclusion they reported that long-term use of statins was associated with
increased risks of both IDC and ILC.
In support of t is here is a comment from
one of my readers that might interest you.
“I recently stopped my statin drugs as I
was experiencing bad muscle pains. My GP actually said that "statins don't
really help women anyway". Hello, why has he then prescribed this and
wasted all my money? “ GD, Brisbane
No comments:
Post a Comment